146 related articles for article (PubMed ID: 36805002)
1. Research Progress on Lipocalin-2 in Diabetic Encephalopathy.
Zhang W; Chen S; Zhuang X
Neuroscience; 2023 Apr; 515():74-82. PubMed ID: 36805002
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond.
Bhusal A; Lee WH; Suk K
Front Physiol; 2021; 12():638112. PubMed ID: 33613327
[TBL] [Abstract][Full Text] [Related]
3. Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy.
Bhusal A; Rahman MH; Lee IK; Suk K
Front Endocrinol (Lausanne); 2019; 10():25. PubMed ID: 30761088
[TBL] [Abstract][Full Text] [Related]
4. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.
Lim D; Jeong JH; Song J
CNS Neurosci Ther; 2021 Aug; 27(8):883-894. PubMed ID: 33945675
[TBL] [Abstract][Full Text] [Related]
5. Review of lipocalin-2-mediated effects in diabetic retinopathy.
Zhang Y; Song X; Qi T; Zhou X
Int Ophthalmol; 2024 Feb; 44(1):78. PubMed ID: 38351392
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications.
Bhusal A; Rahman MH; Lee WH; Bae YC; Lee IK; Suk K
Biochem Pharmacol; 2019 Nov; 169():113626. PubMed ID: 31476294
[TBL] [Abstract][Full Text] [Related]
7. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.
Abella V; Scotece M; Conde J; Gómez R; Lois A; Pino J; Gómez-Reino JJ; Lago F; Mobasheri A; Gualillo O
Biomarkers; 2015; 20(8):565-71. PubMed ID: 26671823
[TBL] [Abstract][Full Text] [Related]
8. Tonicity-responsive enhancer-binding protein promotes diabetic neuroinflammation and cognitive impairment via upregulation of lipocalin-2.
Jeong EA; Lee J; Shin HJ; Lee JY; Kim KE; An HS; Kim DR; Choi KY; Lee KH; Roh GS
J Neuroinflammation; 2021 Nov; 18(1):278. PubMed ID: 34844610
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice.
Guo H; Jin D; Zhang Y; Wright W; Bazuine M; Brockman DA; Bernlohr DA; Chen X
Diabetes; 2010 Jun; 59(6):1376-85. PubMed ID: 20332347
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin 2 receptors: facts, fictions, and myths.
Schröder SK; Gasterich N; Weiskirchen S; Weiskirchen R
Front Immunol; 2023; 14():1229885. PubMed ID: 37638032
[TBL] [Abstract][Full Text] [Related]
11. From the periphery to the brain: Lipocalin-2, a friend or foe?
Ferreira AC; Dá Mesquita S; Sousa JC; Correia-Neves M; Sousa N; Palha JA; Marques F
Prog Neurobiol; 2015 Aug; 131():120-36. PubMed ID: 26159707
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
[TBL] [Abstract][Full Text] [Related]
13. Diverse functional roles of lipocalin-2 in the central nervous system.
Jha MK; Lee S; Park DH; Kook H; Park KG; Lee IK; Suk K
Neurosci Biobehav Rev; 2015 Feb; 49():135-56. PubMed ID: 25511817
[TBL] [Abstract][Full Text] [Related]
14. A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance.
Jun LS; Siddall CP; Rosen ED
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E825-35. PubMed ID: 21771968
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases.
Dekens DW; Eisel ULM; Gouweleeuw L; Schoemaker RG; De Deyn PP; Naudé PJW
Ageing Res Rev; 2021 Sep; 70():101414. PubMed ID: 34325073
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration.
Ip JP; Noçon AL; Hofer MJ; Lim SL; Müller M; Campbell IL
J Neuroinflammation; 2011 Sep; 8():124. PubMed ID: 21943033
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration.
Lee S; Kim JH; Kim JH; Seo JW; Han HS; Lee WH; Mori K; Nakao K; Barasch J; Suk K
J Biol Chem; 2011 Dec; 286(51):43855-43870. PubMed ID: 22030398
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response.
Nairz M; Schroll A; Haschka D; Dichtl S; Sonnweber T; Theurl I; Theurl M; Lindner E; Demetz E; Aßhoff M; Bellmann-Weiler R; Müller R; Gerner RR; Moschen AR; Baumgartner N; Moser PL; Talasz H; Tilg H; Fang FC; Weiss G
Eur J Immunol; 2015 Nov; 45(11):3073-86. PubMed ID: 26332507
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells.
Chan YK; Sung HK; Jahng JW; Kim GH; Han M; Sweeney G
Mol Cell Endocrinol; 2016 Jul; 430():68-76. PubMed ID: 27090568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
